Now showing items 1-10 of 138
Free Cash Flows and the Wealth Effects of Stock Repurchase Announcements
The free cash flow hypothesis predicts that repurchasing firms with free cash flows will have larger announcement-period abnormal returns than repurchasers that do not have free cash flows. We test the free cash flow ...
Is A CURE ON the WAY? – THE BAD MEDICINE OF GENERICS, CITIZEN PETITIONS, AND NOERR-PENNINGTON IMMUNITY
Over the next five years, approximately 110 drugs, including blockbuster products such as Sanofi-Aventis’ allergy medicine Flomax, GlaxoSmithKline’s herpes medication Valtrex, and Pfizer’s cholesterol medication Lipitor ...
Size Matters: The Impact of Physician Practice Size on Productivity
(Johns Hopkins University Carey Business School, 2010-01)
Abstract Physician practices in the US are largely small-scale, independently-run enterprises, despite their potential critical role in creating a more integrated health care system. Using an approach that builds on – ...
Technological Change at Work: The Impact of Employee Involvement on the Effectiveness of Health Information Technology
REVISED VERSION OF https://jscholarship.library.jhu.edu/handle/1774.2/33502?show=full. This paper uses employee and patient survey data from a large, integrated healthcare provider to assess the moderating role that employee ...
A Comprehensive Examination of the Wealth Effects of Recent Stock Repurchase Announcements
In this paper we examine the wealth effect of stock repurchase announcements using a sample of 11,862 repurchase programs announced during 1994-2007. The results of several recent industry surveys indicate that managerial ...
Generic Manufacturers’ Labeling Catch-22
In Wyeth v. Levine, the Supreme Court eliminated brand-name manufacturers’ ability to use the preemption defense against state law failure to warn claims involving allegedly misbranded pharmaceutical drugs. Since that time, ...
1000 Connecticut Avenue